Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia

Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia

IntroductionDespite the improvement in survival in acute lymphoblastic leukemia (ALL), there are still cases with evasion of chemotherapy-induced apoptosis. The IKK/NF-κB signaling pathway contributes to antiapoptotic gene expression. Pentoxifylline (PTX) inhibits IkB phosphorylation, blocking NF-κB...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Violeta Salceda-Rivera, Pablo C. Ortiz-Lazareno, Georgina Hernández-Flores, Jorge R. Vazquez-Urrutia, Jesus Meza-Arroyo, Monzerrat Pardo-Zepeda, Hugo Romo-Rubio, Cesar Barba-Barba, Fernando Sánchez-Zubieta, Carlos Alfredo Barrón-Gallardo, Oscar Gonzalez-Ramella, Alejandro Bravo-Cuellar
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2024-10-01
Saila:Frontiers in Oncology
Gaiak:
MRD
ALL
clinical trials
apoptosis
Pentoxifylline
early remission
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fonc.2024.1401262/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1401262/full

Antzeko izenburuak